Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Up 50.4% in April

Takara Bio Inc. (OTCMKTS:TKBIFGet Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 86,800 shares, a growth of 50.4% from the March 31st total of 57,700 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Takara Bio Stock Performance

Shares of TKBIF opened at $23.20 on Friday. Takara Bio has a 12 month low of $23.20 and a 12 month high of $23.20. The stock has a fifty day moving average price of $23.20 and a 200-day moving average price of $23.20.

About Takara Bio

(Get Free Report)

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.

Read More

Receive News & Ratings for Takara Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takara Bio and related companies with MarketBeat.com's FREE daily email newsletter.